The Research and Innovation (R&I) Annual Report for 2023 – 2024: Delivering Change Together (covering 1 April 2023 to 31 March 2024) details the scope and breadth of R&I at Manchester University NHS ...

Almost half of all UK adults regularly take prescription medicines and the annual NHS budget for medicines is approximately £17.4 billion per year, with over 1.1 billion items prescribed annually.

Patients across GM and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100m of private investment to set up local research hubs.

The Pharmacogenetics Roll Out – Gauging Response to Service [PROGRESS] programme is an NHS England funded transformation project led by researchers at Manchester University NHS Foundation Trust.

Patients across Greater Manchester, and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100 million of private investment to set ...

Recently the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) and the NIHR North West Regional Research Delivery Network collaboratively hosted the ...

Greater Manchester residents are being encouraged to take part in a research study at Manchester Royal Eye Hospital (MREH) that aims to improve the diagnosis and treatment of conditions associated ...

New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.

A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with gentamicin, a commonly used antibiotic, is being trialled across 14 NHS neonatal (specialist ...

Our patients are regularly the first-in-the-world to have the opportunity to trial new treatments, and even more are first in the UK. Research and innovation are key to achieving our vision to be ...

In order to run a Phase I or gene modification (GM) trial at MFT, as part of the MFT Assessment of Capacity and Capability process, your trial will be reviewed by the Early Phase Safety Committee ...